InhaleRx Ltd News

InhaleRx Ltd: Results of General Meeting

Nov 28 16:35 ET

InhaleRx Ltd: Nov24 EGM Slides

Nov 28 00:09 ET

InhaleRx Ltd: Director Appointment and Resignation

Nov 27 18:12 ET

InhaleRx Ltd: Ethics Approval for Phase 2 Clinical Trial of IRX-211

Nov 14 17:33 ET

InhaleRx Ltd: Change in substantial holding - Cannvalate

Nov 13 18:55 ET

InhaleRx Ltd: Sep24 Appendix 4C Cash Flow Report

Oct 31 05:03 ET

InhaleRx Ltd: Sep24 Quarterly Activities Report

Oct 31 05:03 ET

InhaleRx Ltd: General Meeting - Access Letter

Oct 28 18:09 ET

InhaleRx Ltd: Notice of General Meeting

Oct 28 18:08 ET

InhaleRx Ltd: General Meeting - Sample Proxy

Oct 28 18:06 ET

InhaleRx Ltd: Change in substantial holding

Oct 28 04:06 ET

InhaleRx Ltd: Application for quotation of securities - IRX

Oct 24 00:28 ET

InhaleRx Ltd: Cleansing Notice

Oct 22 22:28 ET

InhaleRx Ltd: Issue of Loan Conversion shares

Oct 22 21:04 ET

InhaleRx Ltd: Proposed issue of securities - IRX

Oct 22 21:01 ET

InhaleRx Ltd: Proposed issue of securities - IRX

Oct 17 19:25 ET

InhaleRx Ltd: $38.5m Funding to Fully Fund Clinical Development Plans

Oct 17 19:11 ET

InhaleRx Ltd: Application for quotation of securities - IRX

Oct 3 03:55 ET

InhaleRx Ltd: Proposed issue of securities - IRX

Oct 1 20:03 ET

InhaleRx Ltd: Issue of Shares to CEO in Lieu of Accrued Salary

Oct 1 20:02 ET